Racial differences in fibrosis progression after HCV-related liver transplantation
- PMID: 22743546
- PMCID: PMC3624617
- DOI: 10.1097/TP.0b013e318253f7fa
Racial differences in fibrosis progression after HCV-related liver transplantation
Abstract
Background: Black recipients undergoing liver transplantation (LT) for hepatitis C virus (HCV) have decreased patient and graft survival compared with white recipients, a finding that is primarily limited to black recipients of livers from white donors. The cause(s) for these discrepant outcomes are unclear but may be related to HCV disease recurrence. The rates of HCV-related disease recurrence and liver fibrosis progression among black and white liver transplant recipients have not been investigated.
Methods: In this study, we compared liver fibrosis progression between 105 black and 364 white recipients after HCV-related LT in a multisite cohort study and assessed the impact of donor race.
Results: At 6, 12, and 24 months after LT, there was a significantly higher percentage in the black recipient/white donor (B/W) group with severe fibrosis, defined as stage 3 or 4 (F3/F4), compared with all other recipient/donor race combinations. The adjusted odds ratio of developing F3/F4 for the B/W group was 2.54 (1.49-4.69; reference group, white recipient/white donor). Black recipients with black donors demonstrated a similar rate of progression to F3/F4 as white recipients. Patient survival was also decreased in the B/W group compared with other recipient/donor race combinations.
Conclusion: African American recipients with white donors have more severe fibrosis progression after HCV-related LT. The mechanisms responsible for accelerating fibrosis progression in this high-risk race-mismatched group need to be investigated.
Conflict of interest statement
Figures


Similar articles
-
Impact of donor and recipient race on survival after hepatitis C-related liver transplantation.Transplantation. 2012 Feb 27;93(4):444-9. doi: 10.1097/TP.0b013e3182406a94. Transplantation. 2012. PMID: 22277982 Free PMC article.
-
The effect of donor race on the survival of Black Americans undergoing liver transplantation for chronic hepatitis C.Liver Transpl. 2009 Sep;15(9):1126-32. doi: 10.1002/lt.21835. Liver Transpl. 2009. PMID: 19718638 Free PMC article.
-
Recipient-donor race mismatch for African American liver transplant patients with chronic hepatitis C.Liver Transpl. 2012 May;18(5):524-31. doi: 10.1002/lt.22461. Liver Transpl. 2012. PMID: 22140019 Free PMC article.
-
Advancing donor liver age and rapid fibrosis progression following transplantation for hepatitis C.Gut. 2002 Aug;51(2):248-52. doi: 10.1136/gut.51.2.248. Gut. 2002. PMID: 12117889 Free PMC article.
-
Effects of ethnicity and socioeconomic status on survival and severity of fibrosis in liver transplant recipients with hepatitis C virus.Liver Transpl. 2012 Apr;18(4):461-7. doi: 10.1002/lt.23376. Liver Transpl. 2012. PMID: 22467547 Free PMC article.
Cited by
-
Donor Risk Index for African American liver transplant recipients with hepatitis C virus.Hepatology. 2013 Oct;58(4):1263-9. doi: 10.1002/hep.26478. Epub 2013 Aug 6. Hepatology. 2013. PMID: 23696235 Free PMC article.
-
Management of Hepatitis C Post-liver Transplantation: a Comprehensive Review.J Clin Transl Hepatol. 2015 Jun 28;3(2):140-8. doi: 10.14218/JCTH.2015.00005. Epub 2015 Jun 15. J Clin Transl Hepatol. 2015. PMID: 26357641 Free PMC article. Review.
-
Liver transplantation for chronic hepatitis C virus infection in the United States 2002-2014: An analysis of the UNOS/OPTN registry.PLoS One. 2017 Oct 31;12(10):e0186898. doi: 10.1371/journal.pone.0186898. eCollection 2017. PLoS One. 2017. PMID: 29088255 Free PMC article.
-
A Preliminary Study on Factors That Drive Patient Variability in Human Subcutaneous Adipose Tissues.Cells. 2024 Jul 24;13(15):1240. doi: 10.3390/cells13151240. Cells. 2024. PMID: 39120271 Free PMC article.
-
Pathological Roles of Interleukin-22 in the Development of Recurrent Hepatitis C after Liver Transplantation.PLoS One. 2016 Apr 28;11(4):e0154419. doi: 10.1371/journal.pone.0154419. eCollection 2016. PLoS One. 2016. Retraction in: PLoS One. 2019 Nov 26;14(11):e0225971. doi: 10.1371/journal.pone.0225971. PMID: 27123854 Free PMC article. Retracted.
References
-
- Alter MJ, Kruszon-Moran D, Nainan OV, et al. The prevalence of hepatitis C virus infection in the United States, 1988 through 1994. N Engl J Med. 1999 Aug 19;341(8):556–6. - PubMed
-
- Di Bisceglie AM, Goodman ZD, Ishak KG, et al. Long-term clinical and histopathological follow-up of chronic posttransfusion hepatitis. Hepatology. 1991;14:969–74. - PubMed
-
- Atler 1997 Epidemiology of Hepatitis C. Hepatology. 1997 Sep;26(3 Suppl 1):62S–65S. - PubMed
-
- Charlton M. Hepatitis C infection in liver transplantation. Am J Transplant. 2001 Sep;1(3):197–203. - PubMed
-
- Gane EJ, Portmann BC, Naoumov NV, et al. Long-term outcome of hepatitis C infection after liver transplantation. N Engl J Med. 1996 Mar 28;334(13):815–20. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous